Elite Diagnostic Limited
JMSE:ELITE Voorraadrapport
Marktkapitalisatie: JA$781.0m
Elite Diagnostic Beheer
Beheer criteriumcontroles 0/4 Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Harvey Levers
Algemeen directeur
Percentage CEO-salaris n/a Dienstverband CEO no data Eigendom CEO n/a Management gemiddelde ambtstermijn geen gegevens Gemiddelde ambtstermijn bestuur geen gegevens
Recente managementupdates
Elite Diagnostic Limited Announces Board Changes Dec 16
No independent directors Nov 16
No independent directors Apr 27
Elite Diagnostic Limited, Annual General Meeting, Dec 14, 2020 Nov 20
Toon alle updates
Investor sentiment improves as stock rises 15% Oct 08
Full year 2024 earnings released: EPS: JA$0.074 (vs JA$0.038 in FY 2023) Oct 01
New minor risk - Share price stability Aug 30
Investor sentiment improves as stock rises 22% Aug 21
Full year 2024 earnings released: EPS: JA$0.09 (vs JA$0.038 in FY 2023) Aug 17
Second quarter 2024 earnings released: JA$0.03 loss per share (vs JA$0.021 loss in 2Q 2023) Feb 15
Elite Diagnostic Limited Announces Board Changes Dec 16
First quarter 2024 earnings released: JA$0.02 loss per share (vs JA$0.016 profit in 1Q 2023) Nov 16
Investor sentiment improves as stock rises 16% Oct 31
Investor sentiment deteriorates as stock falls 15% Oct 14
Full year 2023 earnings released: EPS: JA$0.038 (vs JA$0.14 in FY 2022) Oct 01
Full year 2023 earnings released: EPS: JA$0.008 (vs JA$0.14 in FY 2022) Aug 16
New major risk - Share price stability Aug 05
Investor sentiment deteriorates as stock falls 28% Jul 22
New minor risk - Share price stability Jul 07
Third quarter 2023 earnings released: EPS: JA$0.02 (vs JA$0.08 in 3Q 2022) May 21
Investor sentiment deteriorates as stock falls 21% Feb 24
Second quarter 2023 earnings released: JA$0.02 loss per share (vs JA$0.021 profit in 2Q 2022) Feb 18
Investor sentiment deteriorated over the past week Dec 09
No independent directors Nov 16
Investor sentiment deteriorated over the past week May 26
No independent directors Apr 27
Investor sentiment improved over the past week Apr 13
Investor sentiment deteriorated over the past week Dec 14
First quarter 2022 earnings released: JA$0.001 loss per share (vs JA$0.029 loss in 1Q 2021) Nov 14
Full year 2021 earnings released: EPS JA$0.005 (vs JA$0.024 in FY 2020) Oct 03
Full year 2021 earnings released: EPS JA$0.002 (vs JA$0.024 in FY 2020) Aug 18
Third quarter 2021 earnings released: EPS JA$0.01 (vs JA$0.006 loss in 3Q 2020) May 16
Second quarter 2021 earnings released: EPS JA$0.01 (vs JA$0.013 in 2Q 2020) Feb 16
New 90-day low: JA$2.71 Jan 10
Elite Diagnostic Limited, Annual General Meeting, Dec 14, 2020 Nov 20
First quarter 2021 earnings released: JA$0.03 loss per share Nov 15
Full year earnings released - EPS JA$0.024 Oct 01
New 90-day low - JA$3.00 Aug 26
Full year earnings released - EPS JA$0.02 Aug 16
New 90-day low - JA$3.11 Aug 09
CEO Mr. Harvey Levers is Chief Executive Officer of Elite Diagnostic Limited since July 01, 2022 and served as its Executive Director. Mr. Levers. gained extensive senior and executive management experience in ... Show more
Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"display-ssr-flag","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}